Jefferies reiterates Buy on Syndax stock ahead of IPF data

🌐 Investing.com (Cyprus) —
Jefferies reiterates Buy on Syndax stock ahead of IPF data

AI Summary

Jefferies reiterated its Buy rating on Syndax Pharmaceuticals ahead of upcoming idiopathic pulmonary fibrosis (IPF) data. The headline does not specify the timing or expected results of the data release.

Markets Health Syndax Pharmaceuticals Jefferies stock rating IPF clinical data

Read original source →